Akari Therapeutics (AKTX) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

AKTX Akari Therapeutics

Watchlist

1.1890
-0.0110-0.92%

Close Jan 17 16:00 ET

1.1890
0.00000.00%

Post 20:01 ET

31.48MMarket Cap-0.47P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Akari Therapeutics Showcases Advancements in Cancer Treatment
TipRanksJan 13 08:41 ET
European Equities Traded in the US as American Depositary Move Slightly Lower in Thursday Trading
MT NewswiresDec 19, 2024 11:08 ET
Akari Therapeutics Appoints Samir Patel as CEO
TipRanksDec 18, 2024 09:01 ET
Akari Therapeutics: Michael Grissinger Gave Notice of His Resignation From Board on Dec 16 >AKTX
Dow JonesDec 18, 2024 08:53 ET
Akari Therapeutics Announces Samir Patel Appointed as CEO >AKTX
Dow JonesDec 18, 2024 08:52 ET
Akari Therapeutics Announces Key Leadership Appointments
Akari TherapeuticsDec 18, 2024 00:00 ET

Comments

Nov 19, 2024 22:26

May get compliance news pump despite ER.

$Akari Therapeutics (AKTX.US)$

Nov 19, 2024 07:03

$Akari Therapeutics (AKTX.US)$ Reuters· 2 mins ago
Akari Therapeutics Regains Full Nasdaq Compliance

Nov 19, 2024 07:00

$Akari Therapeutics (AKTX.US)$
Akari Therapeutics Regains Full Nasdaq Compliance

Nov 10, 2024 19:30

Merger closing with Peak Bio Nov 13. 50% equity ownership by each company.

$Akari Therapeutics (AKTX.US)$

3

Nov 8, 2024 07:02

$Akari Therapeutics (AKTX.US)$ Reuters· just
Akari Therapeutics PLC - Merger to Result in 50% Equity Ownership for Akari and Peak Bio Shareholders

Read more

US

Overall

No Data